USANA Health Sciences Announces Realignment of Executive Team and Appointment of New Executive Officers
10 5월 2011 - 10:01PM
Business Wire
USANA Health Sciences, Inc. (NYSE:USNA) today announced that
Fred W. Cooper, President and Chief Operating Officer; Jeffrey A.
Yates, Chief Financial Officer; and Mark H. Wilson, Executive Vice
President of Sales have each stepped down from their respective
offices to pursue other business endeavors. The Company also
announced that it has realigned its executive team and appointed
Kevin G. Guest as President of North America, Deborah Woo as
President of Asia Pacific, G. Douglas Hekking as Chief Financial
Officer, and Roy W. Truett as Chief Operating Officer.
Commenting on these new officer appointments, Dave Wentz, Chief
Executive Officer, said, “On behalf of the board of directors and
the management team, I want to offer my congratulations and
gratitude to these outstanding executives who are taking on greater
leadership roles within our company. They are all highly talented
and proven executives who have played significant roles in USANA’s
growth for many years. USANA’s management team is one of the most
experienced in the industry and will continue to grow USANA.”
Continuing on the realignment of the executive team, Wentz said
“I also want to offer Fred, Jeff, and Mark our sincerest
appreciation for their years of service to USANA. We wish them well
in their future endeavors.”
Conference Call
USANA will hold a conference call and webcast to discuss this
announcement with investors on Tuesday, May 10, 2011 at 4:00PM
Eastern Time. Investors may listen to the call by dialing
1-877-941-9205 at least ten minutes prior to the conference or by
accessing USANA’s website at
http://www.usanahealthsciences.com. For those who
cannot listen to the live broadcast, a replay will be available
shortly after the call.
About USANA
USANA develops and manufactures high-quality nutritional,
personal care, and weight-management products that are sold
directly to Associates and Preferred Customers throughout the
United States, Canada, Australia, New Zealand, Hong Kong, Japan,
Taiwan, South Korea, Singapore, Mexico, Malaysia, the Philippines,
the Netherlands, and the United Kingdom. Additionally, USANA’s
wholly-owned subsidiary, BabyCare, Ltd., operates a direct selling
business in China. More information on USANA can be found at
http://www.usanahealthsciences.com.
Safe Harbor
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act and Section 21E of
the Securities Exchange Act. Our actual results could differ
materially from those projected in these forward-looking
statements, which involve a number of risks and uncertainties,
including global economic conditions generally, reliance upon our
network of independent Associates, the governmental regulation of
our products, manufacturing and marketing risks, adverse publicity
risks, and risks associated with our international expansion. The
contents of this release should be considered in conjunction with
the risk factors, warnings, and cautionary statements that are
contained in our most recent filings with the Securities and
Exchange Commission.
USANA Health Sciences (NYSE:USNA)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
USANA Health Sciences (NYSE:USNA)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024